Role of corticotropin-releasing factor, vasopressin and the autonomic nervous system in learning and memory

European Journal of Pharmacology

Volumn 405, Issue 1-3, 2000, Pages 225-234

  Croiset, Gerda ^a   Nijsen, Marjoleen J M A ^a   Kamphuis, Patrick J G H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Autonomic nervous system; Corticotropin releasing factor (CRF); Learning; Memory; Vasopressin

Indexed keywords

ADRENALIN; CATECHOLAMINE DERIVATIVE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR[9-41]; GLUCOCORTICOID; NEUROPEPTIDE; OXYTOCIN; VASOPRESSIN;

ADAPTATION; ALERTNESS; ANXIETY; AROUSAL; ATTENTION; AUTONOMIC NERVOUS SYSTEM; AVERSION; AVOIDANCE BEHAVIOR; BEHAVIOR; BLOOD; BRAIN; BRAIN STEM; CATECHOLAMINE RELEASE; CONDITIONING; CONFERENCE PAPER; CONTROL SYSTEM; ENVIRONMENTAL FACTOR; FEAR; HORMONE RELEASE; LEARNING; MEMORY; MOTIVATION; NERVE PROJECTION; NONHUMAN; PARAVENTRICULAR NUCLEUS; PASSIVE AVOIDANCE; PRIORITY JOURNAL; STIMULUS; STRESS;

ANIMAL; AUTONOMIC NERVOUS SYSTEM; CORTICOTROPIN-RELEASING HORMONE; HUMAN; LEARNING; MEMORY; VASOPRESSINS;

EID: 0034730451     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00556-2     Document Type: Article

References (117)

1. Retention of a passive avoidance response as a function of the intensity and duration of electric shock
2. Differential regulation of hypothalamic pituitary corticotropin releasing hormone receptors during development of adjuvant-induced arthritis in the rat
3. Novel ligand specificity of pituitary vasopressin receptors in the rat
4. Non-peptidic corticotropin-releasing hormone receptor type 1 antagonist reverses restraint stress-induced shortening of sodium pentobarbital-induced sleeping time of rats: evidence that an increase in arousal induced by stress is mediated through CRH receptor type 1
5. Potential neurotrophic factors in the mammalian central nervous system: functional significance in the developing and aging brain
6. Vasopressin and oxytocin receptors in the central nervous system
7. The cholinergic hypothesis of geriatric memory dysfunction
8. Long lasting potention of synaptic transmission in the dentate area of the anaesthetized rabbit, following stimulation of the perforanth path
9. The role of adrenomedullary catecholamines in the modulation of memory by vasopressin
10. Inhibitory avoidance deficit following short-term adrenalectomy in the rat: the role of adrenal catecholamines
11. Neuropeptides and memory: interactions with peripheral catecholamines
12. Central vasopressin impairs the baroreceptor heart rate reflex in conscious rats
13. Stress related behavioral effects of corticotropin-releasing factor
14. Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems
15. Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism
16. Corticotropin-releasing factor: a physiologic regulator of adrenal epinephrine secretion
17. Corticotropin-releasing factor receptor antagonist: effects on the autonomic nervous system and cardiovascular function
18. Intra- and extra-hypothalamic vasopressin and oxytocin pathways in the rat
19. Fragments of pituitary peptides as active principles in the brain: proteolytic formation and biological significance of fragments of neurohypophyseal and pro-opiomelanocortin peptides
20. Central oxytocin systems may mediate a cardiovascular response to acute stress in rats
21. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression
22. Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat
23. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress
24. Corticotropin-releasing factor, stress, and animal behavior
25. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress
26. Plasma catecholamine, corticosterone and glucose responses to repeated stress in rats: effect of interstressor interval length
27. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders
28. Effects of peptide hormones on behavior
29. Long-term effect of vasopressin on the maintenance of a conditioned avoidance response in rats
30. Peptides and behavior
31. Behavioral actions of neurohypophyseal peptides
32. Neurohypophyseal hormone influences on learning and memory processes
33. Neuropeptides and behavior: 1. CNS effects of ACTH, MSH and opioid peptides
34. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats
35. Differential effects of centrally injected vasopressin on heart rate, core temperature, and behavior in rats
36. Corticotropin-releasing factor receptors: an overview
37. Function and molecular basis of action of vasopressin 4-8 and its analogues in rat brain
38. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?
39. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activation in rats
40. Can aversive properties of (peripherally injected) vasopressin account for its putative role in memory?
41. Conditional and unconditional components of post-shock freezing
42. Central autonomic modulation of cardiac baroreflex by corticotropin-releasing factor
43. Corticotropin releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats
44. Corticotropin-releasing factor (CRF): mechanism to elevate mean arterial pressure and heart rate
45. Distribution of CRF-like immunoreactivity in brain-stem of two monkey species (Saimiri sciureus and Macaca fascicularis): an immunohistochemical study
46. Effect of active fragments of arginine-vasopressin on the disturbance of spatial cognition in rats
47. Time-related memory effects of vasopressin analogues in rats
48. Dissociation of oxytocin, vasopressin and corticotropin secretion during different types of stress
49. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
50. Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat
51. The amygdala: corticotropin-releasing factor, steroids, and stress
52. Neuropeptide neuronal efferents from the bed nucleus of the stria terminalis and central amygdaloid nucleus to the dorsal vagal complex in the rat
53. Characterization of corticotropin-releasing factor receptor subtypes
54. Regional hemodynamic responses to central administration of corticotropin-releasing factor (CRF)
55. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm
56. The antagonistic effect of corticotropin-releasing factor on pentobarbital in rats
57. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress
58. Intracerebroventricular administration of corticotropin-releasing factor antagonist attenuates c-fos mRNA expression in the paraventricular nucleus after stress
59. Corticotropin-releasing factor up regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus
60. 8-vasopressin enhances responses of lateral septal neurons in the rat to excitatory aminoacids and fimbria-fornix stimuli
61. Amino acid neurotransmission between fimbria-fornix fibers and neurons in the lateral septum of the rat: a microiontophoretic study
62. Fear-motivated behavior induced by prior shock experience is mediated by corticotropin-releasing hormone systems
63. Anxiolytics and stress induced behavioural and cardiac responses: a study of diazepam and ipsapirone (TVXQ 7821)
64. Conditioned neuroendocrine and cardiovascular stress responsiveness accompanying behavioral passivity and activity in aged and in young rats
65. Central actions of corticotropin-releasing hormone (CRH) on behavioral, neuroendocrine, and cardiovascular regulation: brain corticoid receptor involvement
66. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats
67. Dose-dependent action of corticosteroids on brain serotonin content and passive avoidance behavior
68. Facilitation of memory consolidation by vasopressin: mediation by terminals of the dorsal noradrenergic bundle?
69. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures
70. Release of vasopressin and oxytocin by paraventricular stimulation in rats
71. Vasopressin receptor antagonist prevents behavioural effects of vasopressin
72. Extrapituitary expression of the rat V(1B) vasopressin receptor gene
73. CRF2α and CRF2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues
74. The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism
75. Role of vasopressin in sympathetic response to paraventricular nucleus stimulation in anesthetized rats
76. Sympathetic nervous system activation by glutamate injections into the paraventricular nucleus
77. Blood pressure and heart rate responses to microinjection of vasopressin into the nucleus tractus solitarius region of the rat
78. Memory - a century of consolidation
79. Modulation of memory storage by treatments affecting peripheral catecholamines
80. Adrenergic influences on memory storage: interaction of peripheral and central systems
81. Immunocytochemical localization of corticotrophin releasing factor (CRH) in the rat spinal cord
82. Effects of vasopressin and angiotensin II on neurones in the rat dorsal motor nucleus of the vagus, in vitro
83. The central role of corticotrophin-releasing factor (CRF-41) in psychological stress in rats
84. Conditioned fear-induced tachycardia in the rat: vagal involvement
85. Vagal activation in novelty-induced tachycardia during the light phase in the rat
86. The role of the CRH type 1 receptor in autonomic responses to corticotropin-releasing hormone in the rat
87. Endogenous corticotropin-releasing hormone inhibits conditioned fear-induced vagal activation in the rat
88. Magnocellular hypothalamic projection to the lower brain stem and spinal cord of the rat
89. Cellular localization of vasopressin V(1A) receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature
90. Differentiated hemodynamic responses to central versus peripheral administration of corticotropin-releasing factor in conscious rats
91. Central nervous effects of CRF and angiotensin II on cardiac output in conscious rats
92. Vasopressin antagonist in nucleus tractus solitarius/vagal area reduces pressor and tachycardia responses to paraventricular nucleus stimulation
93. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain
94. Vasopressin: mechanism of central cardiovascular action in conscious rats
95. Differential effect of lesioning of the central amygdala on the bradycardiac and behavioral response of the rat in relation to conditioned social and solitary stress
96. Failure of vasopressin to enhance memory in a passive avoidance task
97. Molecular cloning and characterization of rat V(1B) vasopressin receptor: evidence for its expression in extra pituitary tissues
98. CRF like immunoreactivity in the rat brain as revealed by a modifed cobalt-glucose oxidase diaminobenzidine method
99. Evidence for differential regulation of CRF and vasopressin immunoreactivities in parvocellular neurosecretory and autonomic-related projections of the paraventricular nucleus
100. Differential effects of DGAVP on acquisition and extinction of active avoidance behavior
101. Reduced attention in mice lacking a functional corticotropin-releasing hormone receptor 1
102. Central ANP attenuates pressor responses to central vasopressin in WKY and SHR
103. Organization of ovine CRF immunoreactive cells and fibres in the rat brain: an immunohistochemical study
104. Effects of arginine-vasopressin fragment 4-9 on rodent cholinergic systems
105. Localization and characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography
106. Neuropeptides:effects on paradoxical sleep and theta rhythm in rats
107. Haemodynamic effects of arginine-vasopressin microinjections into the nucleus tractus solitarius: a comparative study of vasopressin, a selective vasopressin receptor agonist and antagonist, and oxytocin
108. Vasopressin and oxytocin: their presence in the central nervous system and their functional significance in brain processes related to behavior and memory
109. In vitro release of vasopressin and oxytocin from rat median eminence tissue
110. Inhibitory effects of neuropeptides on centrally evoked pressor responses
111. Changes in heart rate and body temperature during passive avoidance behavior in rats
112. Corticotropin-releasing factor produces a long-lasting enhancement of synaptic efficacy in the hippocampus
113. Intracerebroventricular CRF inhibits cold restraint-induced c-fos expression in the dorsal motor nucleus of the vagus and gastric erosions in rats
114. Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons
115. Cardiovascular effects of centrally administered vasopressin in conscious and anesthetized rats